Natural killer cells as key players in the vaccine-induced immune response against bovine GI nematodes by González Hernández, Ana et al.
Natural killer cells as key players in the vaccine- induced 
immune response against bovine GI nematodes 
González-Hernández Ana.1; Van Coppernolle S.1; Claerebout E.1; Geldhof P.1 
1Faculty of veterinary medicine, Department of virology, parasitology & immunology. Salisburylaan 133, 9820 Merelbeke, Belgium. 
Introduction 
 
Figure A: At the time of necropsy, mononuclear cells (MC) were isolated from the abomasal (O. ostertagi) or the small intestine (C. oncophora) draining lymph nodes and the proliferation index was calculated based on 
the 3HT uptake as previously described for the systemic response. Figure B: MC were labeled with PKH to identify the proliferative cell populations. 
Conclusion 
Natural killer cells may play a pivotal role on the protective vaccine-induced immune response against both Ostertagia ostertagi and Cooperia oncophora. In the 
case of C. oncophora, other immune cells such as CD4 T cells and B cells might also participate to induce a protective immune response at mucosal level, where 
only NK cell- proliferation is observed, whereas for O. ostertagi NK cells are the main responders both systemically and at the mucosal level. 
 
 
Immunological control of worm infections through vaccination is often put forward as a valuable alternative for anthelmintics to control helminth infections in 
livestock. In recent years, our research group has been able to develop protective experimental vaccines against the two most important and prevalent 
gastrointestinal nematodes in cattle: the abomasal nematode Ostertagia ostertagi and the intestinal nematode Cooperia oncophora, based on activation-
associated proteins (ASP) purified from the excretory-secretory material of adult worms. 
Ostertagia ostertagi Cooperia oncophora 
Aim of the study 
The general aim of our research project is to define the vaccine-induced immune response by both O. ostertagi and C. oncophora antigens since the 
development of the vaccines is largely hampered by the lack of knowledge on the protective immune response needed against these parasites. 
Experimental set up 
· Five groups of 4 animals:  - QuilA control 
     - nASP/QuilA 
     - pASP/QuilA 
     - nASP /Alum 
 


























































































































































Native ASP + QuilA vaccinated
Pichia ASP + QuilA vaccinated













· Two  groups of 7 animals:  - QuilA control 
     - HMW/QuilA 
   
  
   
· Three intramuscular injections followed by a five trickle infection with C. oncophora 




















































































































































































































































Native ASP + QuilA vaccinated
Pichia ASP + QuilA vaccinated













Figure A: The tables show the protection levels obtained with both native vaccines combined with QuilA in the different trials along the years. Protection levels are based in the reduction of the fecal egg counts. Figure B: As 
a measure of proliferation, 3H-Thymidin (3HT) uptake by PBMCs was analyzed each week during the vaccination period. The stimulation index for each time point was calculated by dividing the mean counts per minute 
(CPM) of cultures stimulated with the antigen with the mean cpm of medium stimulated cultures. The combination of the native antigen with QuilA always gave the highest proliferation index. Figure C: Simultaneously to the 






Egg counts (%) 
2000 60 %* 
2002 56 %* 
2007 62 %* 
2007 74 %* 




Egg counts (%) 
2012 90 %* 
2013 70 %* 
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